Takeda | 4502 - Cost Of Sales


Takeda reported JPY560.54B in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Astellas Pharma JPY 129.43B 19.7B Mar/2026
Chugai Pharma JPY 92.79B 5.23B Mar/2026
Daiichi Sankyo JPY 118.28B 37.7B Dec/2025
Eisai JPY 52.02B 931M Mar/2026
Kyowa Hakko Kirin JPY 33B 4.87B Mar/2026
M3 JPY 45.08B 461M Mar/2026
Otsuka Holdings JPY 174.09B 18.65B Mar/2026
Shionogi JPY 32.67B 7.02B Mar/2026
Sumitomo Dainippon JPY 51.26B 5.67B Mar/2026
Takeda JPY 560.54B 159.39B Mar/2026
Terumo JPY 151.3B 7.86B Mar/2026